Karyopharm Therapeutics Inc

Company Snapshot
85 Wells Avenue
Newton, MA 02459
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 385
https://www.karyopharm.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$105,380,000
$206,417,000
$151,861,000
Operating Income
($171,850,000)
($98,271,000)
($142,202,000)
Net Income
($196,273,000)
($124,088,000)
($165,291,000)
2020
Gross Profit
$105,380,000
Operating Income
($171,850,000)
Net Income
($196,273,000)
2021
Gross Profit
$206,417,000
Operating Income
($98,271,000)
Net Income
($124,088,000)
2022
Gross Profit
$151,861,000
Operating Income
($142,202,000)
Net Income
($165,291,000)
The above data on Karyopharm Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Richard Paulson
Director, President and Chief Executive Officer
$1,349,720
$5,545,772
$14,523
$6,910,015
Richard Paulson
$6,910,015
Director, President and Chief Executive Officer
Michael Mason
Executive Vice President Chief Financial Officer, Treasurer and Principal Accounting Officer
$665,048
$2,017,438
$16,546
$2,699,032
Michael Mason
$2,699,032
Executive Vice President Chief Financial Officer, Treasurer and Principal Accounting Officer
Sohanya Cheng
Executive Vice President and Chief Commercial Officer
$650,381
$1,948,422
$13,915
$2,612,718
Sohanya Cheng
$2,612,718
Executive Vice President and Chief Commercial Officer
Michael Mano
Senior Vice President General Counsel and Secretary
$611,383
$1,435,332
$13,692
$2,060,407
Michael Mano
$2,060,407
Senior Vice President General Counsel and Secretary
Stuart Poulton
Executive Vice President and Chief Development Officer
$577,224
$1,190,056
$12,568
$1,779,848
Stuart Poulton
$1,779,848
Executive Vice President and Chief Development Officer
Karyopharm Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us